Epstein Secrets

effrey Epstein [mallto:[email protected]] Sent: Friday, January 21, 2011 7:00 AM To: Alice Jacobs Subject: Re: IMDx Enters into Agreement with Abbott great .. im proud of you On Thu, Jan 20, 2011 at 5:28 PM, Alice Jacobs • I wanted to update you with our latest news. I hope that you're doing wel

ad Menu of Molecular Tests Cambridge, MA January 20, 2011— IMDx (privately held) today announced that they have signed a multi-year agreement with Abbott whereby IMDx will design, develop, regulatory clear, and manufacture assays for the Abbott Molecular FDA cleared, m2000 instrument system to be dist

ectious organisms, Clostridium difficile, Vancomycin-Resistance Enterococci (VRE), Group B Streptococci (GBS), Influenza A/Influenza B (INFA/B), and Herpes Simplex Virus 1 and 2 (HSV 1/2). In addition, two additional tests will be commercialized for use outside the United States for the determination of viral l

EN — the QIAGEN artus C. difficile QS-RGQ MDx Kit. This is the fourth FDA clearance in less than a year for IMDx (3 FDA clearances were obtained for Abbott kits). In April, the FDA cleared the QIAGEN artus C. difficile QS-RGQ MDx Kit, developed and manufactured by IMDx, for use on the QIAGEN QlAsymphony

lopment and manufacture of kits for use on the QlAsymphony RGQ MDx System. Additional tests in the 2014 pipeline include a test for the detection of Herpes Simplex Viruses 1 and 2 in male and female genital and oral lesions and a test for the detection of Group B Streptococcus from enriched cultures taken from

Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu of Molecular Tests Cambridge, MA January 20, 2011— IMDx (privately held) today announced that they have signe

ectious organisms. Clostridium difficile, Vancomycin-Resistance Enterococci (VRE), Group B Streptococci (GBS), Influenza A/Influenza B (INFA/B), and Herpes Simplex Virus 1 and 2 (HSV 1/2). In addition, two additional tests will be commercialized for use outside the United States for the determination of viral